Dr. Rodney Kasan
Director
Albany Medical College
Israel
Biography
Dr. Kasan retired from Teva Pharmaceutical Industries Ltd after 37 years of service. The last position Dr. Kasan held was Corporate VP for Technology (Pharmaceutical) and CTO (Pharmaceutical). He was responsible for the development and approval of over 200 products, both generic drugs and NCE's, including Copaxone ( CMC portion ) in the USA, Europe, Israel and other countries.
Research Interest
Dr. Kasan retired from Teva Pharmaceutical Industries Ltd after 37 years of service. The last position Dr. Kasan held was Corporate VP for Technology (Pharmaceutical) and CTO (Pharmaceutical). He was responsible for the development and approval of over 200 products, both generic drugs and NCE's, including Copaxone ( CMC portion ) in the USA, Europe, Israel and other countries.
